CMV viremia was detected using PCR analysis during the 12-week prophylaxis period in 2 (11%) of 19 patients in the ganciclovir group and all 23 patients in the deferred-therapy group. [7] However, six ...

Cytomegalovirus (CMV) is a ubiquitous herpesvirus that, while often latent in the general population, can become reactivated in individuals with compromised immune systems. Inflammatory bowel disease ...

Cytomegalovirus (CMV) is a ubiquitous member of the Herpesviridae family that can establish latent infections in humans but may reactivate to cause disease in both immunocompromised and, increasingly, ...

NEW ORLEANS — Maribavir, an antiviral once deemed promising for cytomegalovirus (CMV) infection but discarded after a negative phase 3 trial, has been shown to be effective in treatment-resistant and ...

Medically reviewed by Cordelia Nwankwo, MD Key Takeaways CMV is common and stays in the body for life.Congenital CMV can lead to birth defects like hearing loss. CMV is often diagnosed with a blood ...

From February 2023, when the program began, to February 2024, 184 cases of congenital CMV infection or disease were identified among 60,115 infants screened using dried blood spot polymerase chain ...

With no vaccine available, early detection, hygiene practices, and public education are vital to prevent long-term disabilities caused by Human Cytomegalovirus in Kashmir’s children Dr Umer Majeed ...

Researchers from Monash University and the Lions Eye Institute have discovered a tissue protein that acts as a central 'traffic controller' for immune cells and can be hijacked by a virus to weaken ...

Quantification of CMV DNA during NIPS is accurate and sensitive for CMV viral load; stratifies risk for primary maternal infection, cCMV.

A new Weill Cornell Medicine and Oregon Health & Science University co-authored study provides critical insight for the development of a vaccine that can more effectively block the spread of ...

A growing body of work implicates infections as a risk factor for Alzheimer’s disease. In the December 19 Alzheimer’s & Dementia, scientists led by Benjamin Readhead at Arizona State University, Tempe ...